Clinical trials
Terminated Phase 1 trials in Switzerland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 47 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| Swiss Cancer Institute | 4 |
| Amgen | 2 |
| Bayer | 2 |
| Centre Hospitalier Universitaire Vaudois | 2 |
| Hoffmann-La Roche | 2 |
| Insel Gruppe AG, University Hospital Bern | 2 |
| University Hospital, Basel, Switzerland | 2 |
| University of Zurich | 2 |
| Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 5 |
| Melanoma | 5 |
| Neoplasms | 3 |
| Recurrence | 3 |
| Carcinoma, Ovarian Epithelial | 2 |
| Colorectal Neoplasms | 2 |
| Lymphoma | 2 |
| Lymphoma, B-Cell, Marginal Zone | 2 |
| Lymphoma, Follicular | 2 |
| Ovarian Neoplasms | 2 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.